Poster Spotlight 9: Lobular Carcinoma
Session Details
The text of the abstracts will be posted on Monday, November 24.
Moderator
Christos Sotiriou, Institut Jules Bordet, Brussels, Belgium
Presentation numberPD9-01
Comprehensive Genomic Landscape of Invasive Lobular Carcinoma Reveals Distinct Molecular Subtypes
Steffi Oesterreich, University of Pittsburgh and UPMC, Pittsburgh, PA
Presentation numberPD9-02
Epigenetic upregulation of TFAP2B expression drives proliferation and survival in Invasive Lobular Carcinoma
Abdalla Wedn, University of Pittsburgh, School of Medicine, Pittsburgh, PA
Presentation numberPD9-03
Comprehensive genomic profiling and clinically targetable mutations of metastatic invasive lobular and no special type breast cancer
Hannah Maynard, University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA
Presentation numberPD9-04
Context-dependent tumor suppressor role of RHOA in breast cancer through cooperation with CDH1 loss
Higinio Dopeso, Memorial Sloan-Kettering Cancer Center, New York, NY
Presentation numberPD9-05
Whole transcriptome sequencing reveals diagnostic and molecular complexity of lobular carcinoma associated with CDH1 alteration
You-Na Sung, Korea University Anam Hospital, Seoul, Korea, Republic of
Presentation numberPD9-06
Discussant: Translational
Christine Desmedt, KU Leuven, Leuven, Belgium
Presentation numberPD9-07
The Genomic, Transcriptomic, and Immune Hallmarks of Metastatic Lobular Breast Cancer
Guilherme Nader-Marta, Dana-Farber Cancer Institute, Boston, MA
Presentation numberPD9-08
Prevalence of lobular carcinoma in situ in surgical specimens of invasive breast cancer
Alina Zatsepina, Maimonides Medical Center, Brooklyn, NY
Presentation numberPD9-09
Clinical utility of 18F-fluoroestradiol positron emission tomography (FES PET) in patients (pts) with lobular breast cancer
Tanmayi Pai, Emory University, Atlanta, GA
Presentation numberPD9-10
Factors Associated with Early and Late Mortality in Invasive Lobular Carcinoma
Jorge Avila, Montefiore Medical Center, Bronx, NY
Presentation numberPD9-11
The association of breast density with clinicopathological characteristics and survival in patients with early stage ER+ HER2- lobular breast cancer
Josephine Van Cauwenberge, Catholic University of Leuven, Leuven, Belgium
Presentation numberPD9-12
Discussant: Clinical
Otto Metzger, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA